ChartMill assigns a Buy % Consensus number of 84% to BLTE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-02 | Mizuho | Upgrade | Neutral -> Outperform |
| 2025-12-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-20 | Mizuho | Initiate | Neutral |
| 2025-10-31 | Benchmark | Maintains | Buy -> Buy |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Benchmark | Reiterate | Buy -> Buy |
| 2025-03-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-21 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-15 | Maxim Group | Maintains | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | Benchmark | Reiterate | Buy -> Buy |
| 2024-05-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-14 | Maxim Group | Initiate | Buy |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-07 | Benchmark | Reiterate | Buy -> Buy |
| 2023-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
11 analysts have analysed BLTE and the average price target is 116.03 USD. This implies a price decrease of -23.3% is expected in the next year compared to the current price of 151.27.
The consensus rating for BELITE BIO INC - ADR (BLTE) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.